معرفی
Jeffrey Allen Borgia is an Associate Professor at Rush University Medical Center, holding joint appointments in the Department of Anatomy and Cell Biology and Department of Pathology. As Director of the Rush University Cancer Center Biorepository and Biomarker Development Core, he leads initiatives in translational research focused on novel diagnostic test development through multi-Omic profiling of patient specimens.
- Developing high-throughput biomarker discovery platforms using quantitative mass spectrometry and Luminex immunoassays
- Overseeing clinical trial specimen management and biorepository operations
- Specializing in lung cancer biomarkers and cancer cachexia mechanisms
His research program integrates proteomics, glycomics, and circulating autoantibody profiling to improve early detection and treatment selection. Technology platforms include Agilent 6495 QQQ Mass Spectrometry, Luminex FlexMAP 3D, and laboratory automation systems.
Active funding sources include grants from the National Cancer Institute, Brinson Foundation, Swim Across America, and industry collaborators like Serum Detect, Inc. and Tempus AI. His team includes post-doctoral fellows, clinical research coordinators, and laboratory staff working on patient-derived xenograft models and organoid cultures.
